Ikarian Capital, LLC

Q2 2025 13F Holdings

  • Location
    dallas, TX
  • Num holdings

    133

  • Value ($000)

    $520,629

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001778253
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
$24.43M
5 %

501,600

put
CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
$22.63M
4 %

464,488

RARE
RARE

ULTRAGENYX PHARMACEUTICAL IN

COM
$20.47M
4 %

563,100

call
ALNY
ALNY

ALNYLAM PHARMACEUTICALS INC

COM
$18.45M
4 %

56,594

---

SOLENO THERAPEUTICS INC

COM
$16.76M
3 %

200,000

put
---

SOLENO THERAPEUTICS INC

COM
$16.76M
3 %

200,000

call
INSM
INSM

INSMED INC

COM PAR $.01
$16.48M
3 %

163,751

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
$15.64M
3 %

321,000

call
VRNA
VRNA

VERONA PHARMA PLC

SPONSORED ADS
$13.89M
3 %

146,831

CAPR
CAPR

CAPRICOR THERAPEUTICS INC

COM NEW
$13.51M
3 %

1,360,200

put
Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 133